Advances in therapeutic strategies for primary CNS B-cell lymphomas
Authors:
- 3 April 2022
- journal article
- other
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 15 (4) , 295-304
Abstract
Primary CNS lymphoma (PCNSL) has traditionally been treated with induction HD-MTX-based chemotherapy, followed by consolidation whole-brain radiotherapy. However, this approach is associated with s...Keywords
This publication has 86 references indexed in Scilit:
- Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)Journal of Clinical Oncology, 2013
- Diagnosis and treatment of primary CNS lymphomaNature Reviews Neurology, 2013
- Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System LymphomasClinical Cancer Research, 2012
- Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRIClinical Cancer Research, 2012
- Age, gender, and racial differences in incidence and survival in primary CNS lymphomaBritish Journal of Cancer, 2011
- Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomasNeuro-Oncology, 2011
- Primary Central Nervous System Lymphomas: A Validation Study of Array-Based Comparative Genomic Hybridization in Formalin-Fixed Paraffin-Embedded Tumor SpecimensClinical Cancer Research, 2011
- Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trialBritish Journal of Cancer, 2010
- Pharmacokinetic and Tumor Distribution Characteristics of Temsirolimus in Patients with Recurrent Malignant GliomaClinical Cancer Research, 2007
- Temozolomide as salvage treatment in primary brain lymphomasBritish Journal of Cancer, 2007